10 September 2024
Oxford Nanopore Technologies
plc
Oxford
Nanopore seeks discovery in connection with anticipated breach of
contract action
Oxford Nanopore Technologies plc
(LSE: ONT) ("Oxford Nanopore" or "the Group"), the company
delivering a new generation of nanopore-based molecular sensing
technology, today announces that it has filed an ex parte
application under 28 U.S.C. § 1782 in the U.S. District Court for
the Northern District of California, for leave to serve subpoenas
on Complete Genomics, Inc., Innomics Inc. (formerly known as BGI
Americas Corp.), MGI Americas, Inc. ("MGI"), and others in support
of a lawsuit that Oxford Nanopore intends to file in the courts of
England and Wales.
Oxford Nanopore anticipates bringing
claims against BGI Tech Solutions Co., Ltd, BGI Group, BGI, Beijing
Genomics Institute at Shenzhen, MGI Holdings Co., Limited and
MGI Tech Co., Ltd in England for, inter
alia, claims for breach of contractual obligations, claims for
breach of common law obligations of confidence, breach of duties
under the Trade Secrets (enforcement etc.) Regulations 2018, and an
entitlement claim to a license of certain
patents.
Additionally, while not commenting on
future litigation, the Group does not believe BGI's nanopore-based
sequencing technology is able to be used in commercial products
around the World without infringing or misappropriating the Group's
substantial portfolio of proprietary rights.
-ENDS-
For further information, please
contact:
Oxford Nanopore Technologies plc
Investors: ir@nanoporetech.com
Media:
media@nanoporetech.com
Teneo (communications adviser to the
Company)
Tom Murray, Olivia Peters
+44 (0) 20 7353 4200
OxfordNanoporeTechnologies@teneo.com
About Oxford Nanopore Technologies plc:
Oxford Nanopore Technologies' goal
is to bring the widest benefits to society through enabling the
analysis of anything, by anyone, anywhere. The Group has developed
a new generation of nanopore-based sensing technology that is
currently used for real-time, high-performance, accessible, and
scalable analysis of DNA and RNA. The technology is used in more
than 125 countries, to understand the biology of humans, plants,
animals, bacteria, viruses and environments as well as to
understand diseases such as cancer. Oxford Nanopore's technology
also has the potential to provide broad, high impact, rapid
insights in a number of areas including healthcare, food and
agriculture.
For more information please
visit: www.nanoporetech.com